Controlled Release Technologies for Chronotherapy: Current Status and Future Perspectives

被引:4
作者
Bhat, Bhavana B. [1 ]
Mehta, Chetan H. [2 ]
Suresh, Akhil [2 ]
Velagacherla, Varalakshmi [2 ]
Nayak, Usha Y. [2 ]
机构
[1] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut Management, Manipal 576104, Karnataka, India
[2] Manipal Acad Higher Educ, Manipal Coll Pharmaceut Sci, Dept Pharmaceut, Manipal 576104, Karnataka, India
关键词
Biological rhythms; circadian rhythms; chronobiology; chronopharmacokinetics; chronotherapeutics; controlled release systems; synchronization; DRUG-DELIVERY SYSTEM; IN-VITRO; CIRCADIAN-RHYTHMS; PULSATILE RELEASE; COATED TABLETS; STATISTICAL OPTIMIZATION; OSMOTIC-PRESSURE; MATRIX TABLETS; BLOOD-PRESSURE; MORNING SURGE;
D O I
10.2174/1381612829666230423144232
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The expression "as sure as night follows a day" emulates those certain cycles in the environment that are always stable. Circadian rhythms are a group of processes that occur within the body in synchronisation with the external factors in a 24 h cycle. Changes in lifestyle and work shifts have disrupted these stable rhythms, which is a leading cause of lifestyle diseases. Associations between these biological clocks and diseases are abundant. However, it is also known that certain drugs work more efficiently and have minimum toxicity when given during a particular phase of the circadian cycle. Chronotherapeutics focuses on treating diseases according to the endogenous processes which mediate xenobiotic metabolism and drug response at a cellular level. Therefore, treatment of those diseases that show aggravation of symptoms according to the circadian rhythms at a particular time is highly beneficial by chronotherapy. In this article, we have emphasised how the changes in rhythms caused diseases and how chronotherapeutic approaches such as controlled drug release technologies can be a better option for these circadian manipulations that seem to influence all types of disease conditions.
引用
收藏
页码:1069 / 1091
页数:23
相关论文
共 220 条
[1]   Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review [J].
Abdifetah, Omar ;
Na-Bangchang, Kesara .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :5659-5677
[2]  
Abraham A., 2012, SCH RES LIB, V4, P599
[4]  
Adhikari C, 2018, Asian Journal of Pharmaceutical and Clinical Research, V11, P305, DOI [10.22159/ajpcr.2018.v11i9.20423, 10.22159/ajpcr.2018.v11i9.20423, DOI 10.22159/AJPCR.2018.V11I9.20423]
[5]  
Aggarwal V., 2013, J APPL PHARM SCI, V3, P141, DOI [10.7324/JAPS.2013.31025, DOI 10.7324/JAPS.2013.31025]
[6]  
Albert KS., 2004, Patent No. [WO/2004/022038, 2004022038]
[7]   PEAMOtecan, a novel chronotherapeutic polymeric drug for brain cancer [J].
Allen, Jasmine ;
Wang, Juan ;
Zolotarskaya, Olga Yu ;
Sule, Amrita ;
Mohammad, Sajjad ;
Arslan, Shukaib ;
Wynne, Kenneth J. ;
Yang, Hu ;
Valerie, Kristoffer .
JOURNAL OF CONTROLLED RELEASE, 2020, 321 :36-48
[8]   A novel hydrogel plug of Sterculia urens for pulsatile delivery: in vitro and in vivo evaluation [J].
Amrutkar, Jitendra R. ;
Gattani, Surendra G. .
JOURNAL OF MICROENCAPSULATION, 2012, 29 (01) :72-82
[9]   Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin [J].
Anal, AK ;
Stevens, WF ;
Remuñán-López, C .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 312 (1-2) :166-173
[10]  
Ansari KA, 2014, BRAZ J PHARM SCI, V50, P203, DOI 10.1590/S1984-82502011000100021